Skip to Content
Follow us
+97165795384
0
0
Sign in
Contact Us
Home
Offerings
Services
Test by Specialty
Test by Health Risks
Test by Health Conditions
Genomics
GENOMICS
Sanger Sequencing
Whole Genome Sequencing
MOLECULAR & PROTEOMICS STUDIES
AFLP (Amplified Fragment Length Polymorphism)
RAPD (Random Amplified Polymorphic DNA)
T-RFLP (Terminal Restriction Fragment Length Polymorphism)
RFLP (Restriction Fragment Length Polymorphism)
Expression Study
Microarray
RT-PCR
Proteomics Study
NEXT GENERATION SEQUENCING (NGS)
Whole Exome Sequencing
Exome Sequencing
Transcriptome Sequencing
Epigenome Sequencing
Metagenome Sequencing
COI GENE SEQUENCING
Customized Gene Study
Primer Walking Services
sequencing services
DNA Sequencing
16s rRNA Sequencing
18s rRNA Sequencing
26s rRNA Sequencing
28s rRNA Sequencing
EDITING & PUBLISHING SUPPORT
Proof Reading
Plagiarism Checking
Research Paper Editing
Thesis Editing
Dissertation Editing
Life Science Journal List
ADDITIONAL SCIENTIFIC STUDIES
Transcript Services
Customized Services
Nanopore
Nanopore Sequencing
ANALYTICAL TECHNIQUES
HPLC (High-Performance Liquid Chromatography)
UPLC (Ultra-Performance Liquid Chromatography)
FTIR (Fourier Transform Infrared Spectroscopy)
GC-MS (Gas Chromatography-Mass Spectrometry)
NMR (Nuclear Magnetic Resonance)
traning
Training Sessions
Shop
Events
Courses
Company
News
Success Stories
About Us
Jobs
Contact us
Help
Appointment
0
0
Home
Offerings
Services
Test by Specialty
Test by Health Risks
Test by Health Conditions
Genomics
Shop
Events
Courses
Company
News
Success Stories
About Us
Jobs
Contact us
Help
Appointment
+97165795384
Follow us
Sign in
Contact Us
All Products
Myeloproliferative Disorders
BCR-ABL1 KINASE DOMAIN MUTATION ANALYSIS [IRMA] (SDL10602)
-
BCR-ABL1 KINASE DOMAIN MUTATION ANALYSIS [IRMA] (SDL10602)
https://www.scanlabglobal.com/shop/sdl10602-bcr-abl1-kinase-domain-mutation-analysis-irma-sdl10602-3875
https://www.scanlabglobal.com/web/image/product.template/3875/image_1920?unique=18393fc
This test analyzes BCR-ABL1 kinase domain mutations in CML. Positive results indicate resistance to TKIs, guiding alternative therapies to manage treatment-refractory leukemia.
1,790.00
AED
1790.0
AED
1,790.00
AED
1,790.00
AED
Not Available For Sale
This combination does not exist.
Add to cart
Buy now
Add to wishlist
Contact Us
Terms and Conditions
Share
![BCR-ABL1 KINASE DOMAIN MUTATION ANALYSIS [IRMA] (SDL10602)](/web/image/product.product/3875/image_1024/%5BSDL10602%5D%20BCR-ABL1%20KINASE%20DOMAIN%20MUTATION%20ANALYSIS%20%5BIRMA%5D%20(SDL10602)?unique=89ca60f)